Frontiers in digital health
Cure8 research brief
Why This Matters
High first-use usability suggests MyTARGET could be acceptable to many adults with IBD and that targeted refinements (error handling, demonstrating time savings) might improve uptake and recommendation.
Who Should Pay Attention
Adult IBD patients; clinicians evaluating digital self-management tools; researchers and developers of IBD apps.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This was a single-center, cross-sectional usability survey in Germany where 200 adults with IBD installed MyTARGET, received a brief standardized introduction, explored the app for 45 minutes, and completed a 13-item usability questionnaire adapted from a validated telehealth tool.
The study measured overall usability on a 7-point scale and assessed recommendation intention with a Net Promoter Score. Participants in this sample rated the app highly for user-friendliness (mean ~6.65/7) and ease of learning (~6.41/7). Lower scores were reported for error handling/troubleshooting and perceived time savings.
The Net Promoter Score was +16, and overall usability correlated with recommendation intent. The report highlights specific areas (error handling, perceived time benefit) that developers could target in future refinements and suggests that ease of use alone may not predict whether users will recommend an IBD app.
Keep In Mind
Findings are from a single-center, supervised first-use session and reflect usability impressions rather than clinical effectiveness or long-term use. The study is useful for developers and clinics considering implementing app-based support but does not provide outcome data on health or adherence.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFrontiers in digital health
AuthorsVasilyeva-Singer D, Rath T, Kretzschmar C +4 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 8, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Study: Marijuana Use Linked to Improved Quality of Life and Symptom Relief Among ...
A majority of surveyed IBD patients who use marijuana reported better quality of life and relief from symptoms such as nausea, joint pain, insomnia and anxiety — findings of interest to people seeking symptom management...
Associations of polygenic risk scores with intestinal surgery, gastrointestinal cancer, and all-cause mortality in 5,021 individuals with inflammatory bowel disease
This paper explores whether polygenic risk scores (PRS) predict key long-term outcomes after IBD diagnosis — notably intestinal surgery — which could be relevant for risk stratification research and future clinical tools...
Inflammatory Bowel Disease in Kazakhstan: Phenotypes, Disease Activity, and Treatment Patterns from a National Registry
This registry study shows many people with IBD in Kazakhstan had clinically active disease at enrollment and identifies factors linked with active UC and CD. It highlights potential gaps in disease control and...